FTC Sues Hims & Hers Over Alleged Health Data Sharing With Meta, Snap
The action tests the FTC's willingness to pursue telehealth platforms under consumer privacy statutes, with the outcome likely to set disclosure standards across the sector.
The Federal Trade Commission filed suit against telehealth platform Hims & Hers on July 29, 2026, alleging the company shared users' sensitive health information with Meta and Snap without adequate consumer consent, according to the FTC complaint as reported by CBS News. The agency further alleges that Hims & Hers locked consumers into subscription arrangements in ways regulators characterize as deceptive under Section 5 of the FTC Act (15 U.S.C. § 45).
According to the CBS News report citing the FTC filing, the shared data included information the agency described as users' 'most private' health details — categories that may include conditions, prescriptions, and symptom disclosures submitted through the platform's intake forms. The specific technical mechanism alleged — whether pixel tracking, API integration, or another data-transfer method — has not been fully detailed in publicly available excerpts of the complaint as of this publication. The full complaint docket, once filed in federal court, would specify the data-transfer method and the time period at issue.
The FTC has pursued telehealth data-sharing cases previously, including a 2023 action against GoodRx Holdings in which the company agreed to a $1.5 million civil penalty and a prohibition on sharing health data for advertising purposes, per the FTC's public record at ftc.gov. The Hims & Hers case follows a similar legal theory but targets a larger consumer-facing telehealth brand; Hims & Hers reported $872 million in full-year 2024 revenue in its SEC 10-K filing (CIK 0001773751). Whether the FTC is seeking civil penalties, injunctive relief, or both in the current action is not confirmed in available public excerpts of the complaint.
Meta and Snap are named in the suit as recipients of the data, according to CBS News. Neither company has been identified as a co-defendant in available reporting; their precise legal posture in the proceeding — whether named as defendants, relief defendants, or third parties — is unknown and would be clarified in the full court docket, accessible via PACER once the case number is assigned. Hims & Hers had not issued a public statement as of the time of this report.
What remains unknown: the full list of alleged violations and the dollar amount of any civil penalties sought, the specific data categories and number of consumers affected as alleged in the complaint, and whether the FTC acted under its Health Breach Notification Rule or solely under its general unfair or deceptive acts authority. The complete complaint filing on PACER and any forthcoming FTC press release with case details would answer these questions.